This inventor holds 3 USPTO granted patents and 9 published patent applications. Top assignees: Legochem Biosciences, Inc., Lg Life Sciences, Limited. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: Hye Kyung Chang: Innovator in Antibacterial Agents
Introduction
Hye Kyung Chang is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of antibacterial agents, holding a total of 3 patents. His work focuses on compositions and methods that inhibit beta-lactamase, a critical enzyme that can render antibiotics ineffective.
Latest Patents
Chang's latest patents include innovative compositions and methods for inhibiting β-lactamase. He has developed substituted dihydroisoxazole derivatives that serve as effective inhibitors of β-lactamases. These inventions not only provide medical uses for these derivatives but also position them as potential antibacterial agents.
Career Highlights
Throughout his career, Hye Kyung Chang has worked with prominent companies in the biotechnology sector. Notable among these are Legochem Biosciences, Inc. and LG Life Sciences, Limited. His experience in these organizations has contributed to his expertise in developing novel antibacterial solutions.
Collaborations
Chang has collaborated with several professionals in his field, including Sung Yoon Baek and Min Soo Kim. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in combating bacterial resistance.
Conclusion
Hye Kyung Chang's contributions to the field of antibacterial agents through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile